TFPI2 expression is also subject to epigenetic regulation, including DNA methylation and histone modifications, which may serve as clinically relevant biomarkers for cancer diagnosis, prognostication, and individualized therapy (Figure 4, right). Here, TFPI2 is linked to cancer.